Jean-Marc Bellemin

Director of Finance/CFO presso IOVANCE BIOTHERAPEUTICS, INC.

Patrimonio netto: 868 096 $ in data 31/03/2024

51 anni

Consumer Services

Health Technology

Posizioni attive di Jean-Marc Bellemin

Società	Posizione	Inizio	Fine
IOVANCE BIOTHERAPEUTICS, INC.	Comptroller/Controller/Auditor	11/03/2021	-
	Director of Finance/CFO	14/12/2020	-
	Treasurer	14/12/2020	-

Società	Posizione	Inizio	Fine
GRITSTONE BIO, INC.	Director of Finance/CFO	01/01/2018	11/12/2020
Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera.	Corporate Officer/Principal	01/01/2008	01/12/2017

Université Paris Dauphine-PSL	Undergraduate Degree
ESSEC Business School	Masters Business Admin
Université Paris II Panthéon Assas	Graduate Degree

Distribuzione geografica

Francia	4
Stati Uniti	4

Posizioni

Director of Finance/CFO	2
Corporate Officer/Principal	1
Undergraduate Degree	1

Settori

Consumer Services	4
Health Technology	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
IOVANCE BIOTHERAPEUTICS, INC.	Health Technology
GRITSTONE BIO, INC.	Health Technology

Aziende private	1
Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera.	Health Technology